CYDUCT DIAGNOSTICS, INC.

CYduct Diagnostics, Inc.

Equities

CYDX

US23256Q1058

Delayed OTC Markets Other stock markets 09:30:42 2024-06-18 am EDT			5-day change	1st Jan Change
0.127 ^USD	-58.36%		-58.36%	-75.10%

Apr. 02	CYduct Diagnostics, Inc. Announces Positive Study Results for Biomarker Combinations in the Assessment of Breast Cancer	CI
2021	CYduct Diagnostics, Inc. announced a financing transaction	CI

CYduct Diagnostics, Inc. (OTCPK:SNDY.D) signed a letter of intent to acquire all the assets of HHC PREFERRED LLC.

December 01, 2020

CYduct Diagnostics, Inc. (OTCPK:SNDY.D) signed a letter of intent to acquire all the assets of HHC PREFERRED LLC on December 2, 2020. The transaction is expected to close before year-end 2020.

© S&P Capital IQ - 2020

Latest news about CYduct Diagnostics, Inc.

CYduct Diagnostics, Inc. Announces Positive Study Results for Biomarker Combinations in the Assessment of Breast Cancer	Apr. 02	CI
CYduct Diagnostics, Inc. announced a financing transaction	21-11-03	CI
CYduct Diagnostics, Inc. (OTCPK:SNDY.D) completed the acquisition of all the assets of HHC PREFERRED LLC.	21-05-11	CI
CYduct Diagnostics, Inc. (OTCPK:SNDY.D) signed a letter of intent to acquire all the assets of HHC PREFERRED LLC.	20-12-01	CI
Solos Endoscopy, Inc. acquired Assets of CYduct, LLC.	20-11-19	CI
Solos Endoscopy, Inc. Appoints Dom Gatto as CEO and Chairman of the Board	17-06-30	CI
Solos Endoscopy, Inc. Announces Resignation of Robert Segersten as CEO and Chairman of the Board	17-06-14	CI
Dom Gatto Joins to the Board of Directors of Solos Endoscopy, Inc	17-06-09	CI
American Medical Group LLC acquired a controlling stake in Solos Endoscopy, Inc. (OTCPK : SNDY) from Bob Segersten.	17-06-08	CI
Solos Endoscopy, Inc. will Change its Ticker to SNDY from SNDYD	15-09-24	CI
Solos Endoscopy to Begin Distribution of its Endoscopic Instruments in Canada	14-02-20	CI
Solos Endoscopy, Inc. Announces Earnings Results for the Second Quarter and Six Months Ended June 30, 2013	13-08-27	CI
Solos Endoscopy, Inc. Announces Sales Results for the Twelve Months Period Ended 2012 and for the Months October, November and December 2012	13-01-16	CI
Solos Endoscopy, Inc. to Conduct New Testing to Increase Sterilization Life for its MammoView Breast Endoscopy Product Line	12-10-24	CI
Solos Endoscopy, Inc. Reports Earnings Results for the Six Months Ended June 30, 2012; Provides Cash Flow Guidance	12-08-16	CI
Solos Endoscopy, Inc. Announces Availability of 45cm Instruments for Use in Bariatric Procedures	12-07-25	CI
Solos Endoscopy, Inc. Begins Marketing of its New SteriTAP Endoscopic Instrument Line	12-07-13	CI
Solos Endoscopy, Inc. to Expand Internationally its MammoView(R) Breast Endoscopy Product Line	12-06-19	CI
Solos Endoscopy, Inc. Reports Sales Results for the First Quarter Ended March 31, 2012	12-04-30	CI

Chart CYduct Diagnostics, Inc.

Duration

Period

Chart CYduct Diagnostics, Inc.

Company Profile

Sector

-

Calendar

2024-06-19 - The Reg A & Crowdfunding Conference

More about the company

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

Stock Market
Equities
CYDX Stock
News CYduct Diagnostics, Inc.
CYduct Diagnostics, Inc. (OTCPK: SNDY.D) signed a letter of intent to acquire all the assets of HHC PREFERRED LLC.

Protect and grow your investments with the help of our experts

Securing my Investments

fermer